TearScience has created a treatment for evaporative dry eye, a disease that approximately 65 million people suffer from worldwide. For additional information on Tearscience’s offerings, visit www.tearscience.com
TearScience is a CED member since 2006 and many of its employees are actively involved in the CED community. Tim Willis, the President and CEO, spoke at CED’s MedTech Conference in 2008 and attended the Biotech/Life Science conference this year. Nicole Wicker, TearScience’s CFO, spoke at CED’s Direct Connections in March.